XENE
Xenon Pharmaceuticals Inc. · Healthcare
EVP, Drug Discovery James R. Empfield sold $2.2M of Xenon Pharmaceuticals Inc.
Sold$2,211,978
$38.31Price
57,743Shares
−85%Stake
What XENE did after the filing
- The stock from Tue, Aug 16 close, $38.18
- −4.4%
- S&P 500, same days
- −13.4%
Measured over 30 trading days, to the Sep 28 close.
Traded Fri, Aug 12. Filed Tue, Aug 16, 1:36 PM ET, during the session. Returns use the Aug 16 close and the Sep 28 close. Not investment advice.